On 17 April 2014
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 17 April 2014, inter alia, to consider approval of unaudited financial results for the quarter ended 31 March 2014 (Q1).Powered by Capital Market - Live News